弥合图像与数据之间的差距:影像学生物样本库的系统性更新
该综述系统检索了Pubmed、Scopus、Web of Science及CORDIS数据库,最终纳入54个含影像数据的生物样本库,其中疾病导向型33个(61.1%)、人群导向型21个(38.9%),多数位于欧洲(26/54,48.1%),最常涉及的影像模态为MRI(40/54,74.1%),多数需申请获取(38/54,70.4%)。作者结论认为影像学生物样本库可作为整合影像标志物、生物学与临床数据的收集、共享和分析平台,但当前生物样本库中含影像者比例相对较小。
要点
- 影像学生物样本库整合影像标志物与临床数据,是精准医学发展的重要支撑平台。
- 检索到的影像学生物样本库以欧洲、疾病导向型为主,MRI为最常用模态(40/54,74.1%)。
- 多数影像学生物样本库需申请后获取(38/54,70.4%),当前生物样本库中含影像者比例相对较小。
核心结论
- 影像学生物样本库可作为收集、共享和分析整合了影像标志物、生物学与临床数据的医学图像平台;当前生物样本库中仅相对较小比例包含影像并可归类为影像学生物样本库。
研究设计与样本
- 系统综述,检索Pubmed、Scopus和Web of Science于2010年1月至2021年7月发表的英文文献,并检索CORDIS数据库(含collections、projects、project deliverables、project publications和programmes);共检索到9272篇文章,最终纳入54个含影像数据的生物样本库。
诊断标准与关键数值
- 纳入54个含影像数据的生物样本库中,疾病导向型33个(61.1%),人群导向型21个(38.9%);欧洲26/54(48.1%),美洲20/54(37.0%);疾病导向型中神经退行性疾病9/33(27.3%)和肿瘤性疾病9/33(27.3%)为主;入组患者数范围240至3,370,929;影像模态为MRI 40/54(74.1%)、CT 20/54(37.0%)、PET 13/54(24.1%)、超声12/54(22.2%);38/54(70.4%)需申请获取。
临床应用与阅片要点
- 作者认为影像学生物样本库可作为收集、共享和分析整合影像标志物、生物学与临床数据的平台。
- 当前影像学生物样本库以欧洲、疾病导向型为主,且多数需申请后获取,提示此类资源在可及性上存在限制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND OBJECTIVE: The systematic collection of medical images combined with imaging biomarkers and patient non-imaging data is the core concept of imaging biobanks, a key element for fuelling the development of modern precision medicine. Our purpose is to review the existing image repositories fulfilling the criteria for imaging biobanks.
METHODS: Pubmed, Scopus and Web of Science were searched for articles published in English from January 2010 to July 2021 using a combination of the terms: "imaging" AND "biobanks" and "imaging" AND "repository". Moreover, the Community Research and Development Information Service (CORDIS) database ( https://cordis.europa.eu/projects ) was searched using the terms: "imaging" AND "biobanks", also including collections, projects, project deliverables, project publications and programmes.
RESULTS: Of 9272 articles retrieved, only 54 related to biobanks containing imaging data were finally selected, of which 33 were disease-oriented (61.1%) and 21 population-based (38.9%). Most imaging biobanks were European (26/54, 48.1%), followed by American biobanks (20/54, 37.0%). Among disease-oriented biobanks, the majority were focused on neurodegenerative (9/33, 27.3%) and oncological diseases (9/33, 27.3%). The number of patients enrolled ranged from 240 to 3,370,929, and the imaging modality most frequently involved was MRI (40/54, 74.1%), followed by CT (20/54, 37.0%), PET (13/54, 24.1%), and ultrasound (12/54, 22.2%). Most biobanks (38/54, 70.4%) were accessible under request.
CONCLUSIONS: Imaging biobanks can serve as a platform for collecting, sharing and analysing medical images integrated with imaging biomarkers, biological and clinical data. A relatively small proportion of current biobanks also contain images and can thus be classified as imaging biobanks.
KEY POINTS: • Imaging biobanks are a powerful tool for large-scale collection and processing of medical images integrated with imaging biomarkers and patient non-imaging data. • Most imaging biobanks retrieved were European, disease-oriented and accessible under user request. • While many biobanks have been developed so far, only a relatively small proportion of them are imaging biobanks.
引用
- Gabelloni, Faggioni, Borgheresi, et al. Bridging gaps between images and data: a systematic update on imaging biobanks. Eur Radiol. 2022. PMID: 35001159. doi:10.1007/s00330-021-08431-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。